Resorbable Pacing Leads Can Significantly Reduce Risk After Cardiac Surgery
|
By HospiMedica International staff writers Posted on 04 Nov 2022 |
|
Postoperative cardiac arrhythmias are common after cardiac surgery. They are routinely treated with external pacemakers and temporary pacing leads that are prophylactically implanted at the time of surgery. This is inherently associated with several risks: Manually extracting modern stainless steel pacing leads can result in complications as the wires can, in some cases, resist extraction due to tissue in-growth. However, if the leads are cut and left in the body, there is the risk of infection and migration; in the case of the latter, revision surgery may be required. Now, a team of researchers is developing resorbable pacing leads that can significantly reduce risk factors after cardiac surgery.
In the project “Resorbable Molybdenum Temporary Cardiac Electrodes,” or “ReMoTe CarE” for short, researchers from the Fraunhofer Society (Munich, Germany) are investigating a completely new approach: In the future, bioresorbable leads that can be left in the body and then disappear by resorption after a defined period are expected to replace conventional leads. This approach is based on the use of the metal molybdenum (Mo), which offers several advantages, such as the ability to degrade uniformly in the body, biocompatibility, and high mechanical strength and electrical conductivity. For use in bioresorbable pacing leads, it is coated with resorbable biopolymers to electrically insulate the surrounding tissue.
The researchers are testing and optimizing the mechanical, electrical and degradation properties of the materials used. The demonstrators - strands of fine metal wires that are coated with biopolymers - will be tested in preclinical studies. The objective is to avoid the complications associated with non-resorbable pacing leads. This would not only provide great relief to patients but also significantly relieve the burden on both healthcare professionals and the healthcare system.
Related Links:
Fraunhofer Society
Latest Critical Care News
- “Intelligent Tattoo” Method Detects Early Melanoma Signals
- Implantable Wireless Light Device Advances Bladder Cancer Treatment
- Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
- AI-Enabled Wearable Patches Reveal Undetected Hormone Disruption in Infertility
- AI Method Turns Toe Scan into Rapid PAD Screening Tool
- Integrated AI Pulmonary Workflow System Streamlines Detection and Follow-Up
- AI Model Predicts 10-Year Stroke Risk from Standard ECG
- Portable Ultrasound Tool Quantifies Liver Fat with MRI-Like Accuracy
- AI Tool Predicts Risk of Out-of-Hospital Cardiac Arrest
- Implantable Cytokine Device Enables Localized Immunotherapy for Ovarian Cancer
- Wearable Defibrillator Supports Quicker Beta-Blocker Optimization in Women
- High-Frequency Ultrasound Disables Viruses While Sparing Human Cells
- New Nasal Spray Enables Prehospital Neuroprotection in Ischemic Stroke
- AI-Enhanced ECG Screens for Heart Failure Risk in Resource-Limited Settings
Channels
Artificial Intelligence
view channel
Automated Phone Speech Test Identifies Alzheimer’s Pathology for Prescreening
Alzheimer’s disease assessment and trial recruitment often rely on costly, invasive biomarker testing and clinic-based cognitive evaluations, limiting scalability as populations age. Providers and trial... Read more
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read more
Surgical Techniques
view channel
Pink Noise Stimulation Approach Could Support Safer Anesthesia
Maintaining stable unconsciousness during general anesthesia while minimizing drug exposure remains a core perioperative challenge. Sudden nociceptive surges can disrupt anesthetic depth, increasing neurological... Read more
Surgical Robotic System Gains CE Mark for Minimally Invasive Procedures
Cornerstone Robotics’ (CSR; Hong Kong, China) Sentire Endoscopic Surgical System (Sentire Surgical System) has received European Union CE mark certification under the Medical Device Regulation (MDR) for... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
Point of Care
view channel
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read more
Business
view channel
Endologix Adds FDA-Cleared Peripheral Thrombectomy System
Endologix (Santa Rosa, CA, USA) has acquired the Pounce Thrombectomy System from Surmodics, with the transaction closing on May 18, 2026. The FDA-cleared system is indicated for the non-surgical removal... Read more
